Share on

Global Organ Preservation Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Preservation Solution, Transportation Technique, Organ Type & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 3306
Pages: 175
Formats: report pdf report excel report power bi report ppt

Organ Preservation Market Size (2022 to 2027)

The Global Organ Preservation Market size was valued at USD 225.50 million in 2022 and is estimated to grow at a CAGR of 7.8% to reach USD 328.27 million by 2027.

Organ preservation is the supply line for organ transplantation. Organ preservation helps to keep up organs' quality before transplantation as these organs are frail in the outside air and wound up broken once taken out from the human body. Organ preservation assumes a vital part in endeavors to beat the lack of organ benefactors while tending to change socioeconomics of the giver pool by making organs feasible for transplantation that was beforehand not used.

MARKET DRIVERS:

Y-O-Y growth in the number of transplantation surgeries worldwide is majorly promoting the global organ preservation market growth.

Organ preservation solutions are beneficial to keep the organs safe before transplantation surgery in hospitals. The organs such as the heart, kidney, liver, lungs, and others collected from the donor are preserved in specific organ transplantation surgeries. Focus on improving the quality of services and promoting the success rate of transplantation surgery is enhancing the growth rate of the global organ preservation market. The growing number of initiatives by the governments in promoting these solutions is expected to favor the global organ preservation market growth.

The emergence of the latest technology in the medical sector and innovative techniques presents growth opportunities for the global organ preservation market. Creating awareness of different treatment procedures through campaigns and digital advertisements will also help the market players have a tremendous growth rate. The launch of reimbursement schemes by the government in concern towards ordinary people is significantly influencing the demand of the organ preservation market. Furthermore, the prevalence to save the organs and to reduce the risk during organ transplantation is likely to outshine the growth rate of the global organ preservation market.

MARKET RESTRAINTS:

Lack of awareness in managing the techniques due to fewer training programs is slowly hampering the growth rate of the global organ preservation market.

Stringent rules and regulations by the government are one reason for the declining market’s growth rate. These treatment solutions need a high cost that ordinary people cannot afford is a challenging attribute for the market participants. Rapid changes in the economic strategies may also negatively impact the growth rate of the organ preservation market. The shortage of skilled people, especially in undeveloped countries, is impeding the demand of the market.

Impact of COVID-19 on the global organ preservation market:

The public health crisis resulting from the rapid transmission of coronavirus disease has negatively impacted all healthcare sectors. Transplantation is one of the most impacted industries since it depends on a range of facilities that have been overburdened as a result of the COVID-19 outbreak. The restricted movement of medical teams through hospitals, the complexity of Coronavirus delivery, the processing period for SARS-nCOV2 PCR testing in the deceased, the higher threshold for organ acquisition, and the restrictive visitor protocol, the already difficult procedure is made much more difficult by the COVID-19 pandemic. The recent studies from two Italian transplant centers focus on resource organization, organ distribution, virus testing, and transplant service provision during the pandemic. It includes actionable information that highlights benefits and disadvantages. Social distancing, safety systems, Systematic virus screening, and fewer patient visits to the transplant center are strategies to reduce disease exposure to the transplant community and healthcare staff. However, Transplant services will be limited in the future; the transplant population will face additional challenges. Such as improved time control during organ retrieval and implantation, fewer organs and blood products donated, insufficient space in the intensive care unit, and the need to ensure protection results.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Preservation Solution, Transportation Technique, Organ Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Market Leaders Profiled

Essential Pharmaceuticals (U.S.), Dr. Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.).

 

This research report on the global organ preservation market has been segmented and sub-segmented based on preservation solution, transportation technique, organ type, and region.

Organ Preservation Market - By Preservation Solution:

  • U.W.
  • Custodial HTK
  • Perfadex

Based on Preservation Solution, the U.W., i.e., the University of Wisconsin, is likely to hold the most significant share value due to the rising prevalence of organ transplantation. Constant economic growth in developed and developing countries boosts the demand of the market.

Organ Preservation Market - By Transportation Technique:

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

Based on the Transportation technique, Static Cold Storage accounts for a significantly large share in the market due to increasing awareness of the availability of different methods. The Hypothermic Perfusion segment will experience fast growth in the upcoming years.

Organ Preservation Market - By Organ Type:

  • Kidney
  • Liver
  • Lung

Based on the Organ Type, the kidney segment holds the largest share due to the growing number of kidney failure incidences. The adoption of advanced technology in the medical sector is fueling the demand of the market.

Organ Preservation Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American organ preservation market is predicted to have a significant share of the global organ preservation market during the forecast period due to the increasing expenditure on healthcare and the rise in the demand to improve healthcare services.

The European market is the second-largest region in holding the highest shares of the market due to the increase in support from the government, which has come forward to encourage organ donation.

Asia-Pacific is likely to take place as the fastest growth in the market. LATAM and MEA, both the regions, are to show a definite increase in demand.

KEY MARKET PARTICIPANTS:

Some of the noteworthy companies dominating the global organ preservation market profiled in this report are Essential Pharmaceuticals (U.S.), Franz Kohler Chemie GmbH (Germany), Organ Recovery Systems (U.S.), Xvivo Perfusion AB (Sweden), and Waters Medical Systems LLC (U.S.)

RECENT MARKET DEVELOPMENTS:

  • On February 06, 2020, the first series of pediatric donor hearts were preserved and transported using the Paragonix SherpaPak Cardiac Trasport system at the University of Florida and Le Bonheur Children'sChildren's hospital.
  • On February 10, 2020, Paragonix Technologies, Inc. announced the clearance by FDA for its Donor Lung Preservation System- LUNGguard.
  • On January 13, 2020, Paragonix Technologies Inc. had published that it had got approval from the US FDA for the Pancreas Transport System, which is commercially available to Pancreas transplant centers and Organ preservatory organization.
  • On July 17, 2019, MyCartis and XVIVO perfusion A.B. announced to unite together to develop a fast-diagnostic tool to assess the quality of donated organs during ex-vivo Perfusion.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample